GAA Interleukin-13 receptor α2 (IL13Rα2), Ephrin type-A receptor 2 (EphA2), Wilms’ tumor gene 1 (WT1), and survivin were chosen as they are expressed in both high- and low-grade gliomas. This evidence concerns the gene GAA and central nervous system cancer.